“Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Advanced Fibrosis in Type 2 Diabetes Mellitus Patients” (2026) Pakistan Journal of Medical & Cardiological Review, 5(1), pp. 163–174. doi:10.5281/zenodo.18345788.